Metropolis Healthcare Limited (NSE:METROPOLIS)
India · Delayed Price · Currency is INR 529.55
-11.95 (-2.21%)
Jun 3, 2026, 12:30 PM IST
Metropolis Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,900 | 1,450 | 1,278 | 1,429 | 2,142 |
Depreciation & Amortization | 1,337 | 892.3 | 846.45 | 806.27 | 562.1 |
Other Amortization | - | 194.52 | 98.23 | 85.89 | 70.13 |
Loss (Gain) From Sale of Assets | 6.83 | -17.59 | - | -0.08 | 0.16 |
Asset Writedown & Restructuring Costs | -50 | - | - | 1.35 | 2.22 |
Loss (Gain) From Sale of Investments | -33.84 | -75.06 | -11.56 | -6.78 | -4.26 |
Stock-Based Compensation | 80.74 | 70.08 | 14.16 | 2.85 | 68.57 |
Provision & Write-off of Bad Debts | 278.73 | 97.09 | 113.52 | -21.72 | -28.48 |
Other Operating Activities | 519.28 | 173.58 | 247.21 | 103.19 | -115.54 |
Change in Accounts Receivable | -489.68 | -118.89 | -123.7 | 157.72 | 115.87 |
Change in Inventory | 32.32 | 18.75 | 58.98 | 65.15 | -79.37 |
Change in Accounts Payable | -22.8 | 48.38 | 57 | -53.12 | -165.07 |
Change in Other Net Operating Assets | -52.01 | -105.38 | 62.24 | -98.64 | -35.41 |
Operating Cash Flow | 3,507 | 2,627 | 2,641 | 2,471 | 2,533 |
Operating Cash Flow Growth | 33.47% | -0.50% | 6.87% | -2.44% | 1.70% |
Capital Expenditures | -434.89 | -434.1 | -637.61 | -526.34 | -306.63 |
Sale of Property, Plant & Equipment | 2.7 | 20 | - | 1.49 | - |
Cash Acquisitions | -1,134 | -1,312 | -6.5 | -4.51 | -6,379 |
Sale (Purchase) of Intangibles | -76.95 | -252.02 | - | - | - |
Investment in Securities | -606.66 | -48.32 | -271.66 | 932.29 | -800.44 |
Other Investing Activities | 18.69 | 15.77 | 21.65 | 65.01 | 110.62 |
Investing Cash Flow | -2,231 | -2,011 | -894.12 | 467.94 | -7,376 |
Long-Term Debt Issued | 45.37 | - | - | - | 6,000 |
Total Debt Issued | 45.37 | - | - | - | 6,000 |
Long-Term Debt Repaid | -812.66 | -680.87 | -1,382 | -2,242 | -3,791 |
Total Debt Repaid | -812.66 | -680.87 | -1,382 | -2,242 | -3,791 |
Net Debt Issued (Repaid) | -767.29 | -680.87 | -1,382 | -2,242 | 2,209 |
Issuance of Common Stock | 0.07 | 0.1 | 0.03 | 1.84 | 19.75 |
Common Dividends Paid | -207.29 | - | -204.96 | -409.69 | -409.38 |
Other Financing Activities | -178.43 | -185.57 | -224.8 | -273.24 | -194.48 |
Financing Cash Flow | -1,153 | -866.34 | -1,812 | -2,923 | 1,625 |
Foreign Exchange Rate Adjustments | 24.63 | 9.8 | 3.25 | 12.97 | -13.64 |
Miscellaneous Cash Flow Adjustments | 5.7 | 8.21 | -0 | - | 25.29 |
Net Cash Flow | 153.08 | -231.43 | -62.15 | 28.53 | -3,206 |
Free Cash Flow | 3,072 | 2,193 | 2,003 | 1,945 | 2,226 |
Free Cash Flow Growth | 40.06% | 9.50% | 3.01% | -12.65% | 0.84% |
Free Cash Flow Margin | 18.67% | 16.48% | 16.59% | 16.94% | 18.12% |
Free Cash Flow Per Share | 14.86 | 10.65 | 9.74 | 9.46 | 10.82 |
Cash Interest Paid | 244.03 | 185.57 | 224.8 | 273.24 | 183.84 |
Cash Income Tax Paid | 454.85 | 439.75 | 373.84 | 515.8 | 825.12 |
Levered Free Cash Flow | 2,424 | 1,560 | 1,840 | 1,280 | 1,723 |
Unlevered Free Cash Flow | 2,577 | 1,676 | 1,981 | 1,448 | 1,846 |
Change in Working Capital | -532.17 | -157.13 | 54.52 | 71.11 | -163.98 |